MedTrace Logo

LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:

NCT02953613 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2021-08-10

No results posted yet for this study

Summary

The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.

Conditions

Interventions

DEVICE

NIRS/IVUS

Cardiac catheterization using infraredx

Sponsors & Collaborators

  • William Beaumont Hospitals

    lead OTHER

Principal Investigators

  • Ivan Hanson, MD · William Beaumont Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-28
Primary Completion
2017-11-20
Completion
2017-11-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02953613 on ClinicalTrials.gov